Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1284]

From lived experience to informed choice in breast cancer reconstruction

Louise McKenna-Mayes - Co-Founder, TONIBOBANDLOU CIC

From lived experience to informed choice in breast cancer reconstruction ( Louise McKenna-Mayes - Co-Founder, TONIBOBANDLOU CIC )

Transforming radiotherapy skin care by recognising diverse skin reactions

Naman Julka-Anderson - The Royal Marsden NHS Foundation Trust, London, UK

Transforming radiotherapy skin care by recognising diverse skin reactions ( Naman Julka-Anderson - The Royal Marsden NHS Foundation Trust, London, UK )

COVID-19 IgG antibodies induce endothelial activation, barrier dysfunction, and...

Dr Keith McCrae - Cleveland Clinic, Cleveland, USA

COVID-19 IgG antibodies induce endothelial activation, barrier dysfunction, and a prothrombotic state ( Dr Keith McCrae - Cleveland Clinic, Cleveland, USA )

Complement-bound procoagulant platelets predict thrombosis in antiphospholipid...

Dr Keith McCrae - Cleveland Clinic, Cleveland, USA

Complement-bound procoagulant platelets predict thrombosis in antiphospholipid syndrome ( Dr Keith McCrae - Cleveland Clinic, Cleveland, USA )

IP6K1-driven tumour polyphosphate may contribute to immune checkpoint inhibitor...

Dr Keith McCrae - Cleveland Clinic, Cleveland, USA

IP6K1-driven tumour polyphosphate may contribute to immune checkpoint inhibitor-associated thrombosis ( Dr Keith McCrae - Cleveland Clinic, Cleveland, USA )

Rocbrutinib shows strong responses in resistant CLL, including BTKi- and...

Prof Jennifer Woyach - The Ohio State University, Columbus, USA

Rocbrutinib shows strong responses in resistant CLL, including BTKi- and venetoclax-exposed patients ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )

ESMO 2025: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2025: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )

Best practice in precision medicine for prostate cancer

Dr Elena Castro, Dr Pasquale Rescigno, Prof Gert Attard and Dr Axel Heidenreich

Best practice in precision medicine for prostate cancer ( Dr Elena Castro, Dr Pasquale Rescigno, Prof Gert Attard and Dr Axel Heidenreich )

Sacituzumab govitecan improves PFS in first-line metastatic TNBC patients...

Dr Javier C Cortés - Hospital Ruber Internacional, Madrid Spain

Sacituzumab govitecan improves PFS in first-line metastatic TNBC patients unable to receive PD-(L)1 inhibitors ( Dr Javier C Cortés - Hospital Ruber Internacional, Madrid Spain )

Sacituzumab tirumotecan improves progression-free and overall survival in EGFR...

Dr Li Zhang - Sun Yat-sen University Cancer Center, Guangzhou, China

Sacituzumab tirumotecan improves progression-free and overall survival in EGFR-TKI resistant NSCLC ( Dr Li Zhang - Sun Yat-sen University Cancer Center, Guangzhou, China )

177Lu-PSMA-617 in metastatic castration-resistant prostate cancer shows higher...

Dr Kim Nguyen Chi - BC Cancer, British Columbia, Canada

177Lu-PSMA-617 in metastatic castration-resistant prostate cancer shows higher PSA response with lower toxicity ( Dr Kim Nguyen Chi - BC Cancer, British Columbia, Canada )

Domvanalimab, zimberelimab and FOLFOX shows durable survival in advanced HER2...

Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA

Domvanalimab, zimberelimab and FOLFOX shows durable survival in advanced HER2-negative GC/GEJC/EAC ( Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )

More from ecancer